Patents by Inventor Christophe Meune

Christophe Meune has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mid-regional pro-atrial natriuretic peptide (pro-ANP) for the identification of patients with atrial fibrillation with an onset of less than 48 hours ago
    Patent number: 9128103
    Abstract: The invention relates to a method for the determination of the time from onset of atrial fibrillation to presentation in a patient comprising the steps of: providing a sample of a bodily fluid of said patient, determining the level of proANP (SEQ ID NO: 1) or fragments thereof in said sample, correlating the level of proANP or fragments thereof to the time from the onset of atrial fibrillation to presentation of said patient, wherein said fragments have a length of at least 6 amino acid residues.
    Type: Grant
    Filed: July 2, 2012
    Date of Patent: September 8, 2015
    Assignee: B.R.A.H.M.S. GmbH
    Inventor: Christophe Meune
  • MID-REGIONAL PRO-ATRIAL NATRIURETIC PEPTIDE (PRO-ANP) FOR THE IDENTIFICATION OF PATIENTS WITH ATRIAL FIBRILLATION WITH AN ONSET OF LESS THAN 48 HOURS AGO
    Publication number: 20140170771
    Abstract: The invention relates to a method for the determination of the time from onset of atrial fibrillation to presentation in a patient comprising the steps of: providing a sample of a bodily fluid of said patient, determining the level of proANP (SEQ ID NO: 1) or fragments thereof in said sample, correlating the level of proANP or fragments thereof to the time from the onset of atrial fibrillation to presentation of said patient, wherein said fragments have a length of at least 6 amino acid residues.
    Type: Application
    Filed: July 2, 2012
    Publication date: June 19, 2014
    Applicants: B.R.A.H.M.S. GMBH, UNIVERSITE PARIS DESCARTES, ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS
    Inventor: Christophe Meune
  • Blood Glutathione as a Biomarker for Screening Asymptomatic Patients at Risk for Heart Failure
    Publication number: 20110144205
    Abstract: The present invention relates to a method for screening an asymptomatic patient at risk for heart failure, said method comprising measuring the concentration of glutathione in a blood sample obtained from said patient.
    Type: Application
    Filed: October 20, 2010
    Publication date: June 16, 2011
    Applicant: INSERM (Institut National de la Recherche Medicale)
    Inventors: Thibaud Damy, Philippe Le Corvoisier, Catherine Pavoine, Francoise Pecker, Philippe Caramelie, Gisele Bonne, Christophe Meune